Pediatric Pulmonology

Journal

Publication Venue For

  • The association of area deprivation and state child health with respiratory outcomes of pediatric patients with cystic fibrosis in the United States.  56:883-890. 2021
  • Dupilumab for chronic eosinophilic pneumonia..  55:3229-3230. 2020
  • Highlights from the 2019 North American Cystic Fibrosis Conference.  55:2225-2232. 2020
  • Tobacco smoke exposure in pediatric cystic fibrosis: A qualitative study of clinician and caregiver perspectives on smoking cessation.  55:2330-2340. 2020
  • Ataluren/ivacaftor combination therapy: Two N-of-1 trials in cystic fibrosis patients with nonsense mutations.  55:1838-1842. 2020
  • Residential instability, neighborhood deprivation, and pediatric asthma outcomes.  55:1340-1348. 2020
  • Tracheostomy in children: Epidemiology and clinical outcomes.  53:1269-1275. 2018
  • Potential pathogenicity of Inquilinus limosus in a pediatric patient with cystic fibrosis.  53:E21-E23. 2018
  • Sensitivity of ivacaftor to drug-drug interactions with rifampin, a cytochrome P450 3A4 inducer.  53:E6-E8. 2018
  • Toward inclusive therapy with CFTR modulators: Progress and challenges.  52:S4-S14. 2017
  • Risk stratification model to detect early pulmonary disease in infants with cystic fibrosis diagnosed by newborn screening.  51:1168-1176. 2016
  • Adherence to airway clearance therapy in pediatric cystic fibrosis: Socioeconomic factors and respiratory outcomes.  50:1244-1252. 2015
  • Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctors.  50:S3-S13. 2015
  • Novel outcome measures for clinical trials in cystic fibrosis.  50:302-315. 2015
  • Thymic hyperplasia and chylothorax.  50:E37-E39. 2015
  • Non-invasive high-frequency oscillatory ventilation (n-HFOV). Thoughts about a bench model.  48:1250-1251. 2013
  • Clearance of initial mucoid Pseudomonas aeruginosa in patients with cystic fibrosis.  47:1113-1122. 2012
  • Intrathoracic airway obstruction and gastroesophageal reflux: A canine model.  47:1097-1102. 2012
  • Co-existing paradoxical vocal cord motion and asthma in a young child.  47:96-98. 2012
  • Plasma TGF-β1 in pediatric cystic fibrosis: Potential biomarker of lung disease and response to therapy.  46:688-695. 2011
  • Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational Cohort.  45:934-944. 2010
  • Inhaled versus systemic antibiotics and airway inflammation in children with cystic fibrosis and Pseudomonas.  45:281-290. 2010
  • Transforming growth factor-β1 in bronchoalveolar lavage fluid from children with cystic fibrosis.  44:1057-1064. 2009
  • Clinical and molecular characterization of S1118F-CFTR.  44:1003-1009. 2009
  • Association of lower airway inflammation with physiologic findings in young children with cystic fibrosis.  44:503-511. 2009
  • The congenital porto-caval fistula: A unique presentation and novel intervention.  43:196-199. 2008
  • Physiologic, bronchoscopic, and bronchoalveolar lavage fluid findings in young children with recurrent wheeze and cough.  41:709-719. 2006
  • Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis.  41:656-665. 2006
  • Effect of preterm birth on hypoxia-inducible factors and vascular endothelial growth factor in primate lungs.  40:538-546. 2005
  • New concepts of Mycoplasma pneumoniae infections in children.  36:267-278. 2003
  • Effects of variable concentrations of inhaled nitric oxide and oxygen on the lungs of newborn piglets.  34:58-65. 2002
  • Modern statistical techniques for the analysis of longitudinal data in biomedical research.  30:330-344. 2000
  • Acute safety and effects on mucociliary clearance of aerosolized uridine 5′-triphosphate ± amiloride in normal human adults.  23:319. 1997
  • Carotid bodies and ventilatory response to hypoxia in aminophylline‐treated piglets.  20:94-100. 1995
  • International Standard Serial Number (issn)

  • 8755-6863
  • Electronic International Standard Serial Number (eissn)

  • 1099-0496